100 related articles for article (PubMed ID: 22688350)
1. The relationship between E2F family members and tumor growth in colorectal adenocarcinomas: A comparative immunohistochemical study of 100 cases.
Xanthoulis A; Kotsinas A; Tiniakos D; Fiska A; Tentes AA; Kyroudi A; Kittas C; Gorgoulis V
Appl Immunohistochem Mol Morphol; 2014 Jul; 22(6):471-7. PubMed ID: 22688350
[TBL] [Abstract][Full Text] [Related]
2. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
3. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
[TBL] [Abstract][Full Text] [Related]
4. JPO1/CDCA7, a novel transcription factor E2F1-induced protein, possesses intrinsic transcriptional regulator activity.
Goto Y; Hayashi R; Muramatsu T; Ogawa H; Eguchi I; Oshida Y; Ohtani K; Yoshida K
Biochim Biophys Acta; 2006; 1759(1-2):60-8. PubMed ID: 16580749
[TBL] [Abstract][Full Text] [Related]
5. The TRAF-interacting protein (TRAIP) is a novel E2F target with peak expression in mitosis.
Chapard C; Hohl D; Huber M
Oncotarget; 2015 Aug; 6(25):20933-45. PubMed ID: 26369285
[TBL] [Abstract][Full Text] [Related]
6. Disruption of mutually negative regulatory feedback loop between interferon-inducible p202 protein and the E2F family of transcription factors in lupus-prone mice.
Panchanathan R; Xin H; Choubey D
J Immunol; 2008 May; 180(9):5927-34. PubMed ID: 18424712
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of E2F family members in ovarian cancer--an evaluation in a training set of 77 patients.
Reimer D; Sadr S; Wiedemair A; Stadlmann S; Concin N; Hofstetter G; Müller-Holzner E; Marth C; Zeimet AG
Clin Cancer Res; 2007 Jan; 13(1):144-51. PubMed ID: 17200349
[TBL] [Abstract][Full Text] [Related]
8. A role for E2F activities in determining the fate of Myc-induced lymphomagenesis.
Rempel RE; Mori S; Gasparetto M; Glozak MA; Andrechek ER; Adler SB; Laakso NM; Lagoo AS; Storms R; Smith C; Nevins JR
PLoS Genet; 2009 Sep; 5(9):e1000640. PubMed ID: 19749980
[TBL] [Abstract][Full Text] [Related]
9. E2F-1 overexpression correlates with decreased proliferation and better prognosis in adenocarcinomas of Barrett oesophagus.
Evangelou K; Kotsinas A; Mariolis-Sapsakos T; Giannopoulos A; Tsantoulis PK; Constantinides C; Troupis TG; Salmas M; Kyroudis A; Kittas C; Gorgoulis VG
J Clin Pathol; 2008 May; 61(5):601-5. PubMed ID: 17908803
[TBL] [Abstract][Full Text] [Related]
10. Intestinal hyperplasia induced by simian virus 40 large tumor antigen requires E2F2.
Sáenz-Robles MT; Markovics JA; Chong JL; Opavsky R; Whitehead RH; Leone G; Pipas JM
J Virol; 2007 Dec; 81(23):13191-9. PubMed ID: 17855529
[TBL] [Abstract][Full Text] [Related]
11. Induction of cell cycle entry and cell death in postmitotic lens fiber cells by overexpression of E2F1 or E2F2.
Chen Q; Hung FC; Fromm L; Overbeek PA
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4223-31. PubMed ID: 11095619
[TBL] [Abstract][Full Text] [Related]
12. Protein expression profiles and prognostic value of E2F family members in clear cell renal cell carcinoma.
Kim YS; Jung J; Jeong H; Oh HE; Lee JH; Lee ES; Choi JW
Pathol Res Pract; 2020 Apr; 216(4):152880. PubMed ID: 32089412
[TBL] [Abstract][Full Text] [Related]
13. E2F1 and E2F2 induction in response to DNA damage preserves genomic stability in neuronal cells.
Castillo DS; Campalans A; Belluscio LM; Carcagno AL; Radicella JP; Cánepa ET; Pregi N
Cell Cycle; 2015; 14(8):1300-14. PubMed ID: 25892555
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor compensation during mammary gland development in E2F knockout mice.
To B; Andrechek ER
PLoS One; 2018; 13(4):e0194937. PubMed ID: 29617434
[TBL] [Abstract][Full Text] [Related]
15. E2F2 expression induces proliferation of terminally differentiated cardiomyocytes in vivo.
Ebelt H; Zhang Y; Kampke A; Xu J; Schlitt A; Buerke M; Müller-Werdan U; Werdan K; Braun T
Cardiovasc Res; 2008 Nov; 80(2):219-26. PubMed ID: 18628254
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members.
Xu X; Bieda M; Jin VX; Rabinovich A; Oberley MJ; Green R; Farnham PJ
Genome Res; 2007 Nov; 17(11):1550-61. PubMed ID: 17908821
[TBL] [Abstract][Full Text] [Related]
17. E2F4 expression is required for cell cycle progression of normal intestinal crypt cells and colorectal cancer cells.
Garneau H; Paquin MC; Carrier JC; Rivard N
J Cell Physiol; 2009 Nov; 221(2):350-8. PubMed ID: 19562678
[TBL] [Abstract][Full Text] [Related]
18. Differences in DNA binding properties between E2F1 and E2F4 specify repression of the Mcl-1 promoter.
Croxton R; Ma Y; Cress WD
Oncogene; 2002 Feb; 21(10):1563-70. PubMed ID: 11896585
[TBL] [Abstract][Full Text] [Related]
19. Expression of E2F-4 gene in colorectal adenocarcinoma and corresponding covering mucosa: an immunohistochemistry, image analysis, and immunoblot study.
Mady HH; Hasso S; Melhem MF
Appl Immunohistochem Mol Morphol; 2002 Sep; 10(3):225-30. PubMed ID: 12373148
[TBL] [Abstract][Full Text] [Related]
20. Ablation of the transcription factors E2F1-2 limits neuroinflammation and associated neurological deficits after contusive spinal cord injury.
Wu J; Sabirzhanov B; Stoica BA; Lipinski MM; Zhao Z; Zhao S; Ward N; Yang D; Faden AI
Cell Cycle; 2015; 14(23):3698-712. PubMed ID: 26505089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
